Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 4.000
+0.005 (0.13%)
Nov 2, 2026, 5:29 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 105.44 million as of November 2, 2026. It is the 41,047th most valuable company in the world and the 590th biggest in Sweden. Its market cap has increased by 10.74% in one year.
Market Cap
105.44M
Enterprise Value
61.64M
Revenue
n/a
Global Rank
Country Rank
#590 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 105.44M, an increase of 1,421.45%. That is a compound annual growth rate of 9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 105.44M | -13.04% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 163.32M |
| Diamyd Medical AB | 154.36M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 134.36M |
| Initiator Pharma | 133.14M |
| Alzinova AB | 112.04M |
| Biovica International AB | 104.80M |
| OncoZenge AB | 85.84M |